Immune Pathways & Development of Sarcoidosis

Trial Objective

The purpose of this study is to learn more about patients who have sarcoidosis and those who do not in order to define different types of sarcoidosis and what may predict how the disease develops over time.

Epigenetic Regulation of Immune Pathways in Sarcoidosis


This trial is active and currently recruiting.

How to Participate

For more information, call 303.270.2049 or complete the form below.

Who Can Participate

Adult nonsmokers who have biopsy-proven sarcoidosis and who are not on immunosuppressive therapy may be eligible to participate.

Estimated Time Commitment

Up to 2 visits

One blood draw and one bronchoscopy, a procedure that allows doctors to examine your airways.

Trial Location

National Jewish Main Campus, Denver, CO



Trial Sponsors

National Institutes of Health




Any Gender

Principal Investigators

Request More Information